• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502

5-Methyl-6-(1-Piperazinyl)-3-Pyridinecarbonitrile: A Comprehensive Overview

5-Methyl-6-(1-Piperazinyl)-3-Pyridinecarbonitrile is a compound with the CAS number 1223433-30-4, which has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyridine derivatives, characterized by its unique structure and potential applications in drug discovery and development. The molecule features a pyridine ring substituted with a methyl group at position 5, a piperazine moiety at position 6, and a cyano group at position 3. These structural elements contribute to its distinct chemical properties and biological activity.

The synthesis of 5-Methyl-6-(1-Piperazinyl)-3-Pyridinecarbonitrile involves a series of well-established organic reactions, including nucleophilic substitution, condensation, and cyclization processes. Recent advancements in synthetic methodologies have enabled the efficient preparation of this compound with high purity and yield. Researchers have explored various solvent systems and catalysts to optimize the reaction conditions, ensuring scalability for potential industrial applications.

From a pharmacological perspective, 5-Methyl-6-(1-Piperazinyl)-3-Pyridinecarbonitrile has demonstrated promising activity in preclinical studies. The compound exhibits selective binding to various biological targets, including enzymes and receptors, making it a valuable candidate for drug development. For instance, studies have shown that it possesses potent inhibitory effects on kinases involved in cancer cell proliferation. This property underscores its potential as an anti-cancer agent.

Recent research has also highlighted the importance of 5-Methyl-6-(1-Piperazinyl)-3-Pyridinecarbonitrile in the context of neurodegenerative diseases. Its ability to modulate neurotransmitter systems suggests that it could be explored as a therapeutic agent for conditions such as Alzheimer's disease or Parkinson's disease. Furthermore, the compound's bioavailability and pharmacokinetic profile have been extensively studied, providing valuable insights into its suitability for oral administration.

In terms of structural analysis, the pyridine ring serves as the core framework of this molecule, while the methyl group at position 5 contributes to its lipophilicity. The piperazine moiety at position 6 introduces additional nitrogen atoms, enhancing the compound's ability to form hydrogen bonds with biological targets. The cyano group at position 3 imparts electron-withdrawing effects, further modulating the molecule's electronic properties.

The application of computational chemistry techniques has played a pivotal role in understanding the behavior of 5-Methyl-6-(1-Piperazinyl)-3-Pyridinecarbonitrile at the molecular level. Quantum mechanical calculations have provided detailed insights into its electronic structure, while molecular docking studies have revealed potential binding modes with target proteins. These computational approaches have significantly accelerated the drug discovery process by enabling researchers to predict the compound's behavior before experimental validation.

From an environmental standpoint, the ecological impact of 5-Methyl-6-(1-Piperazinyl)-3-Pyridinecarbonitrile has been carefully evaluated. Studies indicate that it undergoes rapid biodegradation under aerobic conditions, minimizing its persistence in aquatic environments. This characteristic aligns with current regulatory requirements for sustainable chemical design.

In conclusion, 5-Methyl-6-(1-Piperazinyl)-3-Pyridinecarbonitrile represents a compelling example of how modern chemical synthesis and pharmacological research can converge to develop innovative therapeutic agents. Its unique structure, coupled with promising biological activity, positions it as a key player in future drug development efforts.

• 151021-42-0(2-(Piperazin-1-yl)nicotinonitrile)
• 149554-29-0(6-Piperazinonicotinonitrile)
• 17782-02-4(2-(Diethylamino)nicotinonitrile)
• 84951-44-0(2-(piperazin-1-yl)pyridine-3-carbonitrile)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)